Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
124 studies found for:    "Aspergillosis"
Show Display Options
Rank Status Study
1 Completed A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).
Condition: Aspergillosis
Intervention: Drug: Anidulafungin, VER002
2 Terminated
Has Results
Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)
Condition: Aspergillosis
Interventions: Drug: voriconazole;   Drug: anidulafungin
3 Completed Galactomannan Antigen in Bronchoalveolar Lavage in the Diagnosis of Invasive Aspergillosis in Neutropenic Patients
Condition: Invasive Aspergillosis
Intervention:
4 Terminated
Has Results
A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children
Condition: Invasive Aspergillosis
Intervention: Drug: Voriconazole
5 Completed
Has Results
Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis
Condition: Invasive Aspergillosis
Intervention: Drug: caspofungin
6 Terminated Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis
Condition: Aspergillosis
Interventions: Drug: Micafungin;   Drug: Liposomal Amphotericin B
7 Terminated Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis
Condition: Invasive Aspergillosis
Intervention: Drug: Micafungin
8 Terminated Micafungin Salvage Mono-therapy in Invasive Aspergillosis
Condition: Invasive Aspergillosis
Interventions: Drug: Micafungin;   Drug: Systemic antifungal therapy
9 Completed Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis
Condition: Aspergillosis
Intervention: Drug: nebulised liposomal amphotericin B
10 Completed Study of FK463 for the Treatment of Invasive Aspergillosis
Condition: Aspergillosis
Intervention: Drug: FK463
11 Unknown  Correlation Between Circulating Galactomannan and Beta-D-glucan and Clinical Outcome of Invasive Aspergillosis
Condition: Invasive Aspergillosis
Intervention:
12 Completed
Has Results
Voriconazole For Chronic Bronchopulmonary Aspergillosis
Condition: Aspergillosis
Intervention: Drug: Voriconazole
13 Completed
Has Results
Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis
Condition: Aspergillosis
Interventions: Drug: voriconazole;   Drug: anidulafungin
14 Withdrawn Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis
Condition: Aspergillosis
Intervention: Drug: Voriconazole, micafungin
15 Completed Diagnosing Pulmonary Aspergillosis in Patients With Hematological Malignancies: A Multicentre Prospective Evaluation of an Aspergillus PCR Assay and a Galactomannan ELISA in Bronchoalveolar Lavage Samples
Condition: Invasive Aspergillosis
Intervention:
16 Recruiting Exhaled Breath Analysis in the Early Detection of Aspergillosis
Condition: Invasive Aspergillosis
Intervention:
17 Completed Diagnosing Invasive Aspergillosis by Polymerase Chain Reaction (PCR) Based Investigation of Bronchoalveolar Lavage Samples During Antifungal Therapy
Condition: Invasive Aspergillosis
Intervention:
18 Withdrawn A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive Aspergillosis
Conditions: Aspergillosis/Blood;   Aspergillosis/Invasive
Interventions: Drug: micafungin;   Drug: voriconazole
19 Completed Trial on the Efficacy and Safety of Two Different Glucocorticoid Dose Regimens in Allergic Bronchopulmonary Aspergillosis
Condition: Allergic Bronchopulmonary Aspergillosis
Intervention: Drug: Glucocorticoids
20 Completed Application of an Electronic Nose in the Early Detection of ASpergillosis
Condition: Pulmonary Invasive Aspergillosis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.